 
|
|
|
|
|
| The TERMIS-EU L’Oréal Recherche & Innovation Awards |
07.08.2010 |
|
|
|
|
|
|
|
|
The Tissue Engineering and Regenerative Medicine International Society-EU (TERMIS) congress was held for the first time in Ireland (Galway – 13-17 june) and was hosted by the Network of Excellence for Functional Biomaterials (NFB). L’Oréal Recherche & Innovation, partner of the congress, awards the best poster and the best podium communication prizes to two young researchers.
|
|
|
|
|
|
|
|
| Scientific collaboration between L’ORÉAL and HµREL® Corporation for the development of a non-animal model for contact allergy |
|
|
|
|
|
|
|
|
|
The company Hurel Corp. and L'Oréal Recherche are engaged in a scientific partnership to develop a microfluidic system for establishing a model for contact allergy, eventually allowing the availability of an in vitro evaluation test for molecules with sensitising potential (Allergy test on a Chip).
|
|
|
|
|
|
|
|
| 4th International Symposium - The Science and Technology of Skin Engineering |
07.01.2006 |
|
|
|
|
|
|
|
|
The 4th International Symposium “The Science and Technology of Skin Engineering” will take place in Shanghai, China this year, 15-17 of october.
|
|
|
|
|
|
|
|
| Alternative Approaches to Animal Testing
|
|
|
|
|
|
|
|
|
|
L’Oréal welcomes the announcement of the first action programme of the European Partnership on Alternative Approaches to Animal Testing (EPAA) . On the 7th of November 2005, together with the Commission, 6 other companies and 7 industry sectors, we contributed to the creation of the EPAA.
|
|
|
|
|
|
|
|
| Xeroderma Pigmentosum: A first |
29/04/2005 |
|
|
|
|
|
|
|
|
For the first time, researchers have succeeded in reconstructing skin in vitro using genetically corrected XP cells, thus opening up the prospect of tissue therapy for Xeroderma Pigmentosum.
|
|
|
|
|
|
|
|
| Episkin, subsidiary of L’Oréal, acquires SkinEthic |
|
|
|
|
|
|
|
|
|
Alternative Approaches to Safety Evaluation: “a top Priority for L’Oréal”
Episkin, subsidiary of L’Oréal, acquires SkinEthic, leader in Tissue Engineering
Acquisition of SkinEthic Places L’Oréal in the front line of Technologies Dedicated to Research and Safety Evaluation
|
|
|
|
|
|